Truqap is really a kinase inhibitor that works by blocking pathways that support the cancer cells survive and mature, so reduces most cancers advancement. Truqap is from a class of medicines referred to as an AKT inhibitor. Truqap gained FDA approval on November 17, 2023, following optimistic final results through https://cliveq350rbb4.tokka-blog.com/profile